Patents by Inventor Matthew Pease

Matthew Pease has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200046361
    Abstract: An implantable closure structure is delivered using minimally invasive techniques and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Application
    Filed: October 16, 2019
    Publication date: February 13, 2020
    Applicant: Pulsar Vascular, Inc.
    Inventors: Joseph ESKRIDGE, Gilbert CLARKE, Matthew PEASE, Gregory Marlin MAST, John Conrad MUSKIVITCH
  • Patent number: 10499927
    Abstract: An implantable closure structure is delivered using minimally invasive techniques, and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: December 10, 2019
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Joseph Eskridge, Gilbert Clarke, Matthew Pease, Gregory Martin Mast, John Conrad Muskivitch
  • Publication number: 20170273688
    Abstract: An implantable closure structure is delivered using minimally invasive techniques, and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Application
    Filed: November 8, 2016
    Publication date: September 28, 2017
    Inventors: Joseph Eskridge, Gilbert Clarke, Matthew Pease, Gregory Martin Mast, John Conrad Muskivitch
  • Patent number: 9510835
    Abstract: An implantable closure structure is delivered using minimally invasive techniques, and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: December 6, 2016
    Assignee: Pulsar Vascular, Inc.
    Inventors: Joseph Eskridge, Gilbert Clarke, Matthew Pease, Gregory Martin Mast, John Conrad Muskivitch
  • Publication number: 20140142608
    Abstract: An implantable closure structure is delivered using minimally invasive techniques, and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Application
    Filed: September 9, 2013
    Publication date: May 22, 2014
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Joseph Eskridge, Gilbert Clarke, Matthew Pease, Gregory Martin Mast, John Conrad Muskivitch
  • Patent number: 8551132
    Abstract: An implantable closure structure is delivered using minimally invasive techniques, and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: October 8, 2013
    Assignee: Pulsar Vascular, Inc.
    Inventors: Joseph Eskridge, Gilbert Clarke, Matthew Pease, Gregory Martin Mast, John Conrad Muskivitch
  • Publication number: 20070255398
    Abstract: Expandable heart valves for minimally invasive valve replacement surgeries are disclosed. The valves are rolled into a first, contracted configuration for minimally invasive delivery and then unrolled or unfurled at the implantation site. One- and two-piece stents may be used in conjunction with a plurality of flexible leaflet-forming membranes. The one-piece stents may include an annulus anchoring section, a sinus section with the membranes attached over sinus apertures, and a rigid outflow section. The two-piece stent may include a primary stent to provide a tubular base at the annulus, and a secondary stent having the membranes that couples within the primary stent. Lockout tabs to secure the stents in their expanded shapes are provided. Also, alignment structure may be provided to ensure concentric unfurling. Anchoring barbs at the stent edges or in the stent body secure the valve within the annulus. Methods of implantation are also provided.
    Type: Application
    Filed: May 16, 2007
    Publication date: November 1, 2007
    Inventors: Jibin Yang, Matthew Pease, Brandon Walsh
  • Publication number: 20070191884
    Abstract: An implantable closure structure is delivered using minimally invasive techniques, and inhibits the migration of liquid and particulate matter from inside a physiological cavity or opening, such as an aneurysm or a septal defect, as well as inhibiting the flow of liquid and particulate matter, such as from an associated blood vessel or chamber, into the physiological cavity or opening. The device has a closure structure that covers the neck or opening of a cavity and has one or more anchoring structures for supporting and retaining the closure structure in place across the cavity or opening.
    Type: Application
    Filed: April 19, 2007
    Publication date: August 16, 2007
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Joseph Eskridge, Gilbert Clarke, Matthew Pease, Gregory Mast, John Muskivitch
  • Publication number: 20070168020
    Abstract: A bifurcated stent includes a first stent section and a second stent section. The first stent section is balloon expandable, has an unexpanded configuration, an expanded configuration, and a tubular wall defining a secondary opening. The secondary stent section is self-expanding and an end of the secondary stent section is engaged to a portion of the tubular wall of the primary stent section defining the secondary opening. The secondary stent section has an unexpanded configuration with a first length and an expanded configuration with a second length where the first length is less than the second length. The secondary stent section is expanded to the expanded configuration after the primary stent section is expanded to the expanded configuration. The secondary stent section forms a portion of the tubular wall of the primary stent section in the unexpanded configuration.
    Type: Application
    Filed: March 21, 2007
    Publication date: July 19, 2007
    Inventors: Gregory Brucker, Enrique Malaret, Todd Hall, David Byrd, Gerald Hubbs, Gregory Furnish, Josh Barber, Indaka Gunasekara, Benjamin Morris, Valerie Futral, Sava Chernomordik, William Mers Kelly, William Reuss, Simon Furnish, Michael Wilson, Hacene Bouadi, John Muskivitch, Matthew Pease, David Rahdert, Travis Rowe, Gregory Ruhf, Brandon Walsh, Claude Vidal, Thomas Banks, Russ Redmond
  • Publication number: 20060173537
    Abstract: Expandable heart valves for minimally invasive valve replacement surgeries are disclosed. The valves are rolled into a first, contracted configuration for minimally invasive delivery and then unrolled or unfurled at the implantation site. One- and two-piece stents may be used in conjunction with a plurality of flexible leaflet-forming membranes. The one-piece stents may include an annulus anchoring section, a sinus section with the membranes attached over sinus apertures, and a rigid outflow section. The two-piece stent may include a primary stent to provide a tubular base at the annulus, and a secondary stent having the membranes that couples within the primary stent. Lockout tabs to secure the stents in their expanded shapes are provided. Also, alignment structure may be provided to ensure concentric unfurling. Anchoring barbs at the stent edges or in the stent body secure the valve within the annulus. Methods of implantation are also provided.
    Type: Application
    Filed: September 2, 2003
    Publication date: August 3, 2006
    Inventors: Jibin Yang, Matthew Pease, Brandon Walsh